William B. Schwartz Division of Nephrology, Boston, Massachusetts.
Institute for Clinical Research and Health Policy Studies, Boston, Massachusetts; Tufts Medical Center, and School of Medicine, Tufts University, Boston, Massachusetts.
Am J Kidney Dis. 2023 Oct;82(4):443-453.e1. doi: 10.1053/j.ajkd.2023.03.012. Epub 2023 May 27.
RATIONALE & OBJECTIVE: Hypertension is a known risk factor for dementia and cognitive impairment. There are limited data on the relation of systolic blood pressure (SBP) and diastolic blood pressure (DBP) with incident cognitive impairment in adults with chronic kidney disease. We sought to identify and characterize the relationship among blood pressure, cognitive impairment, and severity of decreased kidney function in adults with chronic kidney disease.
Longitudinal cohort study.
SETTING & PARTICIPANTS: 3,768 participants in the Chronic Renal Insufficiency Cohort (CRIC) Study.
Baseline SBP and DBP were examined as exposure variables, using continuous (linear, per 10-mm Hg higher), categorical (SBP<120 [reference], 120 to 140,>140mm Hg; DBP<70 (reference), 70 to 80, > 80mm Hg) and nonlinear terms (splines).
Incident cognitive impairment defined as a decline in Modified Mini-Mental State Examination (3MS) score to greater than 1 standard deviation below the cohort mean.
Cox proportional hazard models adjusted for demographics as well as kidney disease and cardiovascular disease risk factors.
The mean age of participants was 58±11 (SD) years, estimated glomerular filtration rate (eGFR) was 44mL/min/1.73m ± 15 (SD), and the median follow-up time was 11 (IQR, 7-13) years. In 3,048 participants without cognitive impairment at baseline and with at least 1 follow-up 3MS test, a higher baseline SBP was significantly associated with incident cognitive impairment only in the eGFR>45mL/min/1.73m subgroup (adjusted hazard ratio [AHR], 1.13 [95% CI, 1.05-1.22] per 10mm Hg higher SBP]. Spline analyses, aimed at exploring nonlinearity, showed that the relationship between baseline SBP and incident cognitive impairment was J-shaped and significant only in the eGFR>45mL/min/1.73m subgroup (P=0.02). Baseline DBP was not associated with incident cognitive impairment in any analyses.
3MS test as the primary measure of cognitive function.
Among patients with chronic kidney disease, higher baseline SBP was associated with higher risk of incident cognitive impairment specifically in those individuals with eGFR>45mL/min/1.73m.
PLAIN-LANGUAGE SUMMARY: High blood pressure is a strong risk factor for dementia and cognitive impairment in studies of adults without kidney disease. High blood pressure and cognitive impairment are common in adults with chronic kidney disease (CKD). The impact of blood pressure on the development of future cognitive impairment in patients with CKD remains unclear. We identified the relationship between blood pressure and cognitive impairment in 3,076 adults with CKD. Baseline blood pressure was measured, after which serial cognitive testing was performed over 11 years. Fourteen percent of participants developed cognitive impairment. We found that a higher baseline systolic blood pressure was associated with an increased risk of cognitive impairment. We found that this association was stronger in adults with mild-to-moderate CKD compared with those with advanced CKD.
高血压是痴呆和认知障碍的已知危险因素。关于慢性肾脏病(CKD)成人中收缩压(SBP)和舒张压(DBP)与认知障碍发生率之间的关系,数据有限。我们旨在确定并描述 SBP、DBP 与 CKD 成人肾功能下降严重程度之间的关系。
纵向队列研究。
慢性肾功能不全队列研究(CRIC)中的 3768 名参与者。
将基线 SBP 和 DBP 作为暴露变量进行检查,使用连续(线性,每 10mmHg 升高)、分类(SBP<120[参考]、120 至 140、>140mmHg;DBP<70[参考]、70 至 80、>80mmHg)和非线性项(样条)。
认知障碍的发生定义为改良的迷你精神状态检查(3MS)评分下降超过队列平均值 1 个标准差。
使用 Cox 比例风险模型调整人口统计学以及肾脏疾病和心血管疾病危险因素。
参与者的平均年龄为 58±11(SD)岁,估计肾小球滤过率(eGFR)为 44mL/min/1.73m ± 15(SD),中位随访时间为 11(IQR,7-13)年。在 3048 名基线时无认知障碍且至少有 1 次随访 3MS 测试的参与者中,仅在 eGFR>45mL/min/1.73m 亚组中,较高的基线 SBP 与认知障碍的发生显著相关(调整后的危险比[AHR],每升高 10mmHg SBP 为 1.13[95%CI,1.05-1.22])。旨在探索非线性的样条分析表明,基线 SBP 与认知障碍发生率之间的关系呈 J 形,仅在 eGFR>45mL/min/1.73m 亚组中具有统计学意义(P=0.02)。在任何分析中,基线 DBP 均与认知障碍的发生无关。
3MS 测试作为认知功能的主要测量指标。
在 CKD 患者中,较高的基线 SBP 与认知障碍的发生风险增加相关,特别是在 eGFR>45mL/min/1.73m 的患者中。